Z. Palacios

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial

J. Rodríguez-Baño, Á. Pascual, L. LAVIN-ALCONERO, 2015, BMJ Open.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)

J. De La Torre, C. Hidalgo-Tenorio, P. Arazo, 2019, BMC Infectious Diseases.

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

D. Podzamczer, J. Blanco, M. Laguno, 2020, Clinical Microbiology and Infection.

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Nikolaos A. Triarides, H. Goossens, A. Georgescu, 2023, EClinicalMedicine.